Related Experiment Video
Updated: Jul 4, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Desensitization for sulfasalazine skin rash
Annals of Internal Medicine
|April 1, 1984
Summary
This study shows that most inflammatory bowel disease patients with sulfasalazine allergy can be safely desensitized using a liquid suspension protocol, even if a rash recurs. Serious reactions exclude patients from this desensitization method.
Area of Science:
- Gastroenterology
- Clinical Pharmacology
Background:
- Sulfasalazine is a key medication for inflammatory bowel disease (IBD).
- Allergic reactions, particularly skin rash, limit its use in some IBD patients.
- Desensitization offers a potential alternative for patients allergic to sulfasalazine.
Purpose of the Study:
- To evaluate the safety and efficacy of a sulfasalazine desensitization protocol for IBD patients with documented hypersensitivity.
- To determine if acetylator phenotype influences desensitization success.
Main Methods:
- Thirteen IBD patients with sulfasalazine allergy (skin rash +/- fever) underwent a desensitization protocol.
- A liquid suspension of sulfasalazine at two concentrations was used.
- Patient outcomes and adverse events, including rash recurrence, were monitored.
Main Results:
- Twelve out of thirteen patients (92%) were successfully desensitized.
- Four patients developed a rash during the protocol; one patient discontinued the protocol.
- Rash recurred in one patient on two occasions but did not prevent successful desensitization.
- No association was found between acetylator phenotype and desensitization success.
Conclusions:
- A sulfasalazine desensitization protocol using a liquid suspension is safe and effective for most IBD patients with rash-related allergies.
- This protocol can be safely implemented despite potential rash recurrence during induction.
- Patients with severe sulfasalazine reactions (e.g., agranulocytosis, toxic epidermal necrolysis) are not candidates for this desensitization approach.
Related Concept Videos
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...